cis-urocanic acid
Small moleculeexperimental
Clinical trial activity
4 trials · 10 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2009 (NCT01458847)
Timeline
Indications
Mechanism of action
- Unspecified targetSupplementation
supplementation
Chemistry & pharmacology
Loading structure…
SMILES
O=C(O)/C=C\c1c[nH]cn1- Mol. weight
- 138.13 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1316726 ↗
Also known as
- cis-urocanic acid
- cis-urocanic acid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02326090 | Phase 2 | Dec 1, 2014 | Herantis Pharma Plc., ORA, Inc. |
| NCT01476332 | Phase 1 | Nov 1, 2011 | Kuopio University Hospital, Laurantis Pharma, Ltd. |
| NCT01320579 | Phase 2 | Mar 1, 2011 | BioCis Pharma Ltd, University of Helsinki |
| NCT01458847 | Phase 1 | Oct 1, 2009 | BioCis Pharma Ltd, Clinical Research Services Turku, FinnMedi Oy, University of Tampere, University of Turku |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (10)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BioCis Pharma Ltd | For profit | 2 | 2 | 2 | 2009 |
| Clinical Research Services Turku | For profit | 1 | 0 | 1 | 2009 |
| FinnMedi Oy | For profit | 1 | 0 | 1 | 2009 |
| Herantis Pharma Plc. | For profit | 1 | 1 | 1 | 2014 |
| Kuopio University Hospital | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Laurantis Pharma, Ltd. | For profit | 1 | 1 | 1 | 2011 |
| ORA, Inc. | For profit | 1 | 0 | 1 | 2014 |
| University of Helsinki | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of Tampere | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Turku | Academic/Hospital | 1 | 0 | 1 | 2009 |
10 organizations
Page 1 / 1